Vulnerability · Published Mar 13, 2025 · Assigned by icscert
CVE-2025-2229Philips Intellispace Cardiovascular (ISCV) Use of Weak Credentials
High 7.7
In plain English
A high-severity security flaw in Intellispace Cardiovascular (ISCV) from Philips. There are no confirmed reports of exploitation so far. The chance it is exploited in the next 30 days is estimated at 0.1% (higher than 2% of all known vulnerabilities).
Severity (CVSS 3.1)7.7High
Exploit odds (30 days)0.1%top 97.6% of all CVEs
Exploited in the wildNo reportsCISA SSVC: none
Attack toolingNoneno public tooling known
Official description
A token is created using the username, current date/time, and a fixed AES-128 encryption key, which is the same across all installations.
Affected products (as reported)
| Vendor | Product | Versions |
|---|---|---|
| Philips | Intellispace Cardiovascular (ISCV) | 0 – through 4.1 |
Weakness: CWE-1391 · Vector: CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N